Cited by 1,866Hemoglobinopathies and Related DisordersBlood transfusion and managementAcute Ischemic Stroke Management

Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography

Open access
Adams, Robert J., McKie, Virgil C., Hsu, Lewis, Files, Beatrice, Vichinsky, Elliott, Pegelow, Charles, Abboud, Miguel, Gallagher, Dianne +18 more·1998·New England Journal of Medicine

Abstract

BACKGROUND: Blood transfusions prevent recurrent stroke in children with sickle cell anemia, but the value of transfusions in preventing a first stroke is unknown. We used transcranial Doppler ultrasonography to identify children with sickle cell anemia who were at high risk for stroke and then randomly assigned them to receive standard care or transfusions to prevent a first stroke. METHODS: To enter the study, children with sickle cell anemia and no history of stroke had to have undergone two transcranial Doppler studies that showed that the time-averaged mean blood-flow velocity in the internal carotid or middle cerebral artery was 200 cm per second or higher. The patients were randomly assigned to receive standard care or transfusions to reduce the hemoglobin S concentration to less than 30 percent of the total hemoglobin concentration. The incidence of stroke (cerebral infarction or intracranial hemorrhage) was compared between the two groups. RESULTS: A total of 130 children (mean [+/-SD] age, 8.3+/-3.3 years) were enrolled; 63 were randomly assigned to receive transfusions and 67 to receive standard care. At base line, the transfusion group had a slightly lower mean hemoglobin concentration (7.2 vs. 7.6 g per deciliter, P=0.001) and hematocrit (20.4 vs. 21.7 percent, P=0.002). Ten patients dropped out of the transfusion group, and two patients crossed over from the standard-care group to the transfusion group. There were 10 cerebral infarctions and 1 intracerebral hematoma in the standard-care group, as compared with 1 infarction in the transfusion group -- a 92 percent difference in the risk of stroke (P<0.001). This result led to the early termination of the trial. CONCLUSIONS: Transfusion greatly reduces the risk of a first stroke in children with sickle cell anemia who have abnormal results on transcranial Doppler ultrasonography.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm199807023390102

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Chronic prophylactic transfusions prevent stroke in 90% of children with high cerebral blood velocities measured by transcranial Doppler.

    “chronic prophylactic transfusions prevent stroke in 90% of children with high cerebral blood velocities as measured by transcranial Doppler (148).”

    From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [148]

    The Results report that transfusions lowered the risk of a first stroke by 92% compared with standard care—close to the claimed 90%. But the study was limited to children with sickle cell anemia and confirmed high Doppler velocities; it did not establish that transfusions prevent stroke in 90% of children with high velocities generally. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 7

  1. [2]2. Adams RJ. Neurologic complications. In: Embury SH, Hebbel RP, Mo- handas N, Steinberg MH, eds. Sickle cell disease: scientific principles and clinical practice. New York: Raven Press, 1994:599-621.
  2. [3]3. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular ac- cidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-94.
  3. [6]6. Aaslid R. Developments and principles of transcranial Doppler. In: Newell DW, Aaslid R, eds. Transcranial Doppler. New York: Raven Press, 1992:1-8.
  4. [13]13. Adams RJ, McKie VC, Brambilla D, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials 1997;12:110-29.
  5. [14]14. Adams RJ, Litaker M, Nichols FT. Anemia and sickle cell disease. In: Babikian V, Wechsler LR, eds. Transcranial Doppler ultrasonography. St. Louis: Mosby-Year Book, 1993:160-71.
  6. [26]26. Moser FG, Miller ST, Bello JA, et al. The spectrum of brain MR ab- normalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol 1996;17:965-72.
  7. [27]27. Ohene-Frempong K. Stroke in sickle cell disease: demographic, clini- cal, and therapeutic considerations. Semin Hematol 1991;28:213-9.

Cited by

Sorted by citations

Authors
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., Bonds, D. R., Brambilla, D., Woods, G., Olivieri, N., Driscoll, C., Miller, S., Wang, W., Hurlett, A., Scher, C., Berman, B., Carl, E., Jones, A. M., Roach, E. S., Wright, E., Zimmerman, R. A., & Waclawiw, M.
Affiliations
  • Augusta University (US)
  • Emory University (US)
  • East Carolina University (US)
  • University of Miami (US)
  • Medical University of South Carolina (US)
  • New England Research Institutes (US)
  • National Institutes of Health (US)
  • Children's National (US)
  • St. Jude Children's Research Hospital (US)
  • NewYork–Presbyterian Hospital (US)
  • Tulane University (US)
Venue
New England Journal of Medicine
Published
1998-07-02
Volume
339
Issue
1
Pages
5-11
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2314213298
Cited by
1,866
References
22
Citations by year
2026: 64 · 2025: 55 · 2024: 78 · 2023: 59 · 2022: 92 · 2021: 77 · 2020: 87 · 2019: 74 · 2018: 68 · 2017: 107 · 2016: 124 · 2015: 70 · 2014: 75 · 2013: 82 · 2012: 92
FWCI
22.02
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • New England Research Institutes
  • National Heart, Lung, and Blood Institute (U10HL052016, U10HL052193)
Topics
  • Health Sciences › Medicine › Genetics › Hemoglobinopathies and Related Disorders
  • Health Sciences › Medicine › Biochemistry › Blood transfusion and management
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
Keywords
sickle cell disease, stroke prevention, blood transfusion, transcranial Doppler, cerebral infarction, intracranial hemorrhage, children, cerebral blood flow velocity
MeSH terms
Adolescent, Anemia, Sickle Cell, Blood Flow Velocity, Blood Transfusion, Cerebral Hemorrhage, Cerebral Infarction, Cerebrovascular Circulation, Cerebrovascular Disorders, Child, Child, Preschool, Female, Hemoglobin, Sickle, Humans, Male, Risk, Incidence, Ultrasonography, Doppler, Transcranial, Disease-Free Survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review